In this piece for Hindustan Times, Anup Malani and Reuben Abraham discuss that allocation, distribution, financing, communication and certification are the five key issues for devising an efficient COVID-19 vaccination strategy for India.

Excerpts:

"India has now approved the vaccines developed by Astra-Zeneca and Bharat Biotech. Several more will likely be available later in 2021. Deploying these vaccines effectively will be crucial. India and other developing countries have to keep their specific circumstances in mind while formulating vaccine strategies."

"India will not need to vaccinate 1.35 billion people, but just beyond the point where the reproductive rate is under control even without suppression. "

Read the entire article here.